Lifeward Ltd. announced on May 19, 2025, the appointment of Mark Grant as its new President and Chief Executive Officer, effective June 2, 2025. Larry Jasinski, the outgoing CEO, will serve as Co-CEO and in an advisory capacity until the end of June to assist with the transition.
Mr. Grant brings 30 years of experience in commercial leadership, channel development, and strategic solutions, including various leadership roles at Medtronic. His expertise spans field and inside sales, managed markets, health economics, and global customer service.
The Board of Directors expressed confidence that Grant is the ideal choice to lead Lifeward into its next stage of growth, leveraging his experience to drive innovations and achieve balanced, sustainable growth towards profitability. An inducement award of 400,000 options to purchase ordinary shares was approved for Mr. Grant.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.